Coronavirus: Commission approves contract with CureVac to ensure access to a potential vaccine

Nov 16, 2020

European Commission Press release Brussels, 17 Nov 2020 Today, the European Commission approved a fifth contract with the European pharmaceutical company CureVac, which provides for the initial purchase of 225 million doses on behalf of all EU Member States.


Other news